300 related articles for article (PubMed ID: 1835441)
1. Single-dose 8-OH-DPAT pretreatment does not induce tachyphylaxis to the 5-HT release-reducing effect of 5-HT1A autoreceptor agonists.
Hjorth S
Eur J Pharmacol; 1991 Jun; 199(2):237-42. PubMed ID: 1835441
[TBL] [Abstract][Full Text] [Related]
2. Receptor reserve for 5-hydroxytryptamine1A-mediated inhibition of serotonin synthesis: possible relationship to anxiolytic properties of 5-hydroxytryptamine1A agonists.
Meller E; Goldstein M; Bohmaker K
Mol Pharmacol; 1990 Feb; 37(2):231-7. PubMed ID: 1968223
[TBL] [Abstract][Full Text] [Related]
3. cis-(+)-8-OH-1-CH3-DPAT, (+)ALK-3, a novel stereoselective pharmacological probe for characterizing 5-HT release-controlling 5-HT1A autoreceptors. An in vivo brain microdialysis study.
Hjorth S; Sharp T; Liu Y
Naunyn Schmiedebergs Arch Pharmacol; 1990 Mar; 341(3):149-57. PubMed ID: 1692973
[TBL] [Abstract][Full Text] [Related]
4. Further investigation of the in vivo pharmacological properties of the putative 5-HT1A antagonist, BMY 7378.
Sharp T; Backus LI; Hjorth S; Bramwell SR; Grahame-Smith DG
Eur J Pharmacol; 1990 Feb; 176(3):331-40. PubMed ID: 1970304
[TBL] [Abstract][Full Text] [Related]
5. Interactions of (+)- and (-)-8- and 7-hydroxy-2-(di-n-propylamino)tetralin at human (h)D3, hD2 and h serotonin1A receptors and their modulation of the activity of serotoninergic and dopaminergic neurones in rats.
Lejeune F; Newman-Tancredi A; Audinot V; Millan MJ
J Pharmacol Exp Ther; 1997 Mar; 280(3):1241-9. PubMed ID: 9067310
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological characterization of 8-OH-DPAT-induced inhibition of rat hippocampal 5-HT release in vivo as measured by microdialysis.
Sharp T; Bramwell SR; Hjorth S; Grahame-Smith DG
Br J Pharmacol; 1989 Nov; 98(3):989-97. PubMed ID: 2574066
[TBL] [Abstract][Full Text] [Related]
7. Effect of the 5-HT1A receptor agonist 8-OH-DPAT on the release of 5-HT in dorsal and median raphe-innervated rat brain regions as measured by in vivo microdialysis.
Hjorth S; Sharp T
Life Sci; 1991; 48(18):1779-86. PubMed ID: 1826937
[TBL] [Abstract][Full Text] [Related]
8. Effect of WAY-100135 on the hippocampal acetylcholine release potentiated by 8-OH-DPAT, a serotonin1A receptor agonist, in normal and p-chlorophenylalanine-treated rats as measured by in vivo microdialysis.
Nakai K; Fujii T; Fujimoto K; Suzuki T; Kawashima K
Neurosci Res; 1998 May; 31(1):23-9. PubMed ID: 9704975
[TBL] [Abstract][Full Text] [Related]
9. Chronic administration of the 5-HT1A receptor agonist 8-OH-DPAT differentially desensitizes 5-HT1A autoreceptors of the dorsal and median raphe nuclei.
Kreiss DS; Lucki I
Synapse; 1997 Feb; 25(2):107-16. PubMed ID: 9021891
[TBL] [Abstract][Full Text] [Related]
10. Different effects on the responses of functional pre- and postsynaptic 5-HT1A receptors by repeated treatment of rats with the 5-HT1A receptor agonist 8-OH-DPAT.
Larsson LG; Rényi L; Ross SB; Svensson B; Angeby-Möller K
Neuropharmacology; 1990 Feb; 29(2):85-91. PubMed ID: 1691832
[TBL] [Abstract][Full Text] [Related]
11. Direct evidence for an important species difference in the mechanism of 8-OH-DPAT-induced hypothermia.
Bill DJ; Knight M; Forster EA; Fletcher A
Br J Pharmacol; 1991 Aug; 103(4):1857-64. PubMed ID: 1833017
[TBL] [Abstract][Full Text] [Related]
12. Effects of the 5-hydroxytryptamine receptor antagonist, BMY 7378, on 5-hydroxytryptamine neurotransmission: electrophysiological studies in the rat central nervous system.
Chaput Y; de Montigny C
J Pharmacol Exp Ther; 1988 Jul; 246(1):359-70. PubMed ID: 2839669
[TBL] [Abstract][Full Text] [Related]
13. Differential regulation of somatodendritic serotonin 5-HT1A receptors by 2-week treatments with the selective agonists alnespirone (S-20499) and 8-hydroxy-2-(Di-n-propylamino)tetralin: microdialysis and autoradiographic studies in rat brain.
Casanovas JM; Vilaró MT; Mengod G; Artigas F
J Neurochem; 1999 Jan; 72(1):262-72. PubMed ID: 9886078
[TBL] [Abstract][Full Text] [Related]
14. Responses of hippocampal pyramidal cells to putative serotonin 5-HT1A and 5-HT1B agonists: a comparative study with dorsal raphe neurons.
Sprouse JS; Aghajanian GK
Neuropharmacology; 1988 Jul; 27(7):707-15. PubMed ID: 2901680
[TBL] [Abstract][Full Text] [Related]
15. 8-Hydroxy-2-(di-n-propylamino) tetralin is devoid of activity at the 5-hydroxytryptamine autoreceptor in rat brain. Implications for the proposed link between the autoreceptor and the [3H] 5-HT recognition site.
Middlemiss DN
Naunyn Schmiedebergs Arch Pharmacol; 1984 Aug; 327(1):18-22. PubMed ID: 6238235
[TBL] [Abstract][Full Text] [Related]
16. 5-hydroxytryptamine (5-HT)1A receptors and the tail-flick response. I. 8-hydroxy-2-(di-n-propylamino) tetralin HBr-induced spontaneous tail-flicks in the rat as an in vivo model of 5-HT1A receptor-mediated activity.
Millan MJ; Bervoets K; Colpaert FC
J Pharmacol Exp Ther; 1991 Mar; 256(3):973-82. PubMed ID: 1826033
[TBL] [Abstract][Full Text] [Related]
17. 5-HT1 agonists reduce 5-hydroxytryptamine release in rat hippocampus in vivo as determined by brain microdialysis.
Sharp T; Bramwell SR; Grahame-Smith DG
Br J Pharmacol; 1989 Feb; 96(2):283-90. PubMed ID: 2466516
[TBL] [Abstract][Full Text] [Related]
18. Differential effect of gepirone on presynaptic and postsynaptic serotonin receptors: single-cell recording studies.
Blier P; de Montigny C
J Clin Psychopharmacol; 1990 Jun; 10(3 Suppl):13S-20S. PubMed ID: 1973935
[TBL] [Abstract][Full Text] [Related]
19. Mediation of the discriminative stimulus properties of 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) by the putative 5-HT1A receptor.
Tricklebank MD; Neill J; Kidd EJ; Fozard JR
Eur J Pharmacol; 1987 Jan; 133(1):47-56. PubMed ID: 2881789
[TBL] [Abstract][Full Text] [Related]
20. Repeated treatment with the 5-HT1A receptor agonist, ipsapirone, does not affect 8-OH-DPAT- and stress-induced increases in plasma adrenaline levels in the rat.
Baudrie V; Chaouloff F
Eur J Pharmacol; 1991 Jun; 198(2-3):129-35. PubMed ID: 1830845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
